These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Failure of 3,4-diaminopyridine to reverse conduction block in inflammatory demyelinating neuropathies.
    Author: Bergin PS, Miller DH, Hirsch NP, Murray NM.
    Journal: Ann Neurol; 1993 Sep; 34(3):406-9. PubMed ID: 8363359.
    Abstract:
    3,4-Diaminopyridine was administered to 6 patients with inflammatory demyelinating neuropathies in whom partial conduction block was demonstrable. Four had Guillain-Barré syndrome and 2 had chronic inflammatory demyelinating neuropathy. Nerve conduction studies were performed before the administration of a single oral dose of 3,4-diaminopyridine, and at regular intervals thereafter. Neither resolution of conduction block nor clinical benefit were seen.
    [Abstract] [Full Text] [Related] [New Search]